Article

Women With RA or Lupus Give Birth to Fewer Children

More than half of women who have rheumatoid arthritis (RA) or systemic lupus erythematosus (SLE) have fewer children than desired, according to a new study.

More than half of women who have rheumatoid arthritis (RA) or systemic lupus erythematosus (SLE) have fewer children than desired, according to a new study. The findings suggest that higher rates of infertility and miscarriage also may affect the number of offspring born to women with these chronic conditions.

To further understand the role of infertility, pregnancy loss, and family size choice in women with RA and SLE, investigators from several institutes surveyed 1017 women participating in the National Data Bank for Rheumatic Diseases. Respondents to a reproductive-health questionnaire were categorized as women interested in having children at symptom onset who had fewer children than planned or the same number as planned and those no longer interested in having children at diagnosis.

More than 60% of respondents were no longer interested in having children at diagnosis; 55% of women with RA and 64% of those with SLE had fewer children than originally planned. Overall, the infertility rate among patients with RA was 42% in women who had fewer children than desired. In those who received a diagnosis of RA during their childbearing years, the infertility rate was higher than in those with a diagnosis after childbearing was complete. For patients with SLE, no significant increase in infertility was noted.

The authors suggested that patient education to enhance awareness of safe medical options during pregnancy and effective control of these autoimmune diseases helps women achieve their childbearing goals. The findings were published in Arthritis & Rheumatism, an American College of Rheumatology journal.

Related Videos
Orrin Troum, MD: Accurately Imaging Gout With DECT Scanning
John Stone, MD, MPH: Continuing Progress With IgG4-Related Disease Research
Philip Conaghan, MBBS, PhD: Investigating NT3 Inhibition for Improving Osteoarthritis
Rheumatologists Recognize the Need to Create Pediatric Enthesitis Scoring Tool
Presence of Diffuse Cutaneous Disease Linked to Worse HRQOL in Systematic Sclerosis
Alexei Grom, MD: Exploring Safer Treatment Options for Refractory Macrophage Activation Syndrome
Jack Arnold, MBBS, clinical research fellow, University of Leeds, Leeds Institute of Rheumatic and Musculoskeletal Medicine
John Tesser, MD, Adjunct Assistant Professor of Medicine, Midwestern University, and Arizona College of Osteopathic Medicine, and Lecturer, University of Arizona Health Sciences Center, and Arizona Arthritis & Rheumatology Associates
Gaith Noaiseh, MD: Nipocalimab Improves Disease Measures, Reduces Autoantibodies in Sjogren’s
Laure Gossec, MD, PhD: Informing Physician Treatment Choices for Psoriatic Arthritis
© 2024 MJH Life Sciences

All rights reserved.